Purpose Women of African ancestry (AA) have lower WBC counts and are more likely to
have treatment delays and discontinue adjuvant breast cancer therapy early compared with …

Introduction Black women appear to have worse outcome after diagnosis and treatment of
breast cancer. It is still unclear if this is because Black race is more often associated with …

Background Despite improvements, disparities in breast cancer care have led to an
inequitable distribution of treatment delays and worse outcomes among patients with breast …

Background. Racial differences in breast cancer survival may be in part due to variation in
patterns of care. To better understand factors influencing survival disparities, we evaluated …

Background Despite the survival benefit associated with adjuvant chemotherapy in early-
stage breast cancer, many do not complete treatment. This study identified factors …

Background Black race is associated with worse outcome in patients with breast cancer. The
distant relapse‐free survival (DRFS) between Black and White women with localized breast …

This review explores factors potentially contributing to the disparity in survival after breast
cancer between African‐American and Caucasian women in the United States. A number of …

Purpose Disparities in receipt of adjuvant chemotherapy may contribute to higher breast
cancer fatality rates among black and Hispanic women compared with non-Hispanic whites …

Background Breast cancer survival disparities by race are likely multifactorial. In a small pilot
cohort, we demonstrated a statistical interaction between age and race. The purpose of this …

Background Completion of prescribed neoadjuvant chemotherapy for breast cancer is
paramount to patients obtaining full benefit from the treatment; however, factors affecting …